Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
High-Throughput Nucleotide Sequencing | 21 | 2024 | 3631 | 1.500 |
Why?
|
Mutation | 55 | 2024 | 30025 | 1.060 |
Why?
|
Genomics | 14 | 2024 | 5806 | 0.730 |
Why?
|
Neoplasms | 20 | 2024 | 22083 | 0.730 |
Why?
|
Genome, Human | 12 | 2020 | 4423 | 0.710 |
Why?
|
Tumor Virus Infections | 2 | 2020 | 438 | 0.700 |
Why?
|
Phosphatidylinositol 3-Kinases | 11 | 2018 | 2860 | 0.670 |
Why?
|
Proto-Oncogene Proteins B-raf | 11 | 2014 | 2052 | 0.660 |
Why?
|
DNA Mutational Analysis | 21 | 2021 | 4108 | 0.560 |
Why?
|
Computational Biology | 6 | 2020 | 3510 | 0.530 |
Why?
|
Sequence Analysis, DNA | 12 | 2019 | 4735 | 0.520 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 12 | 2019 | 897 | 0.510 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2021 | 1605 | 0.500 |
Why?
|
Genotype | 12 | 2020 | 12976 | 0.470 |
Why?
|
Carcinoma | 4 | 2019 | 2328 | 0.460 |
Why?
|
DNA Copy Number Variations | 11 | 2019 | 2017 | 0.440 |
Why?
|
Adenocarcinoma | 8 | 2018 | 6330 | 0.430 |
Why?
|
Bifidobacterium | 2 | 2003 | 98 | 0.430 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2018 | 491 | 0.420 |
Why?
|
Endometrial Neoplasms | 2 | 2020 | 1365 | 0.410 |
Why?
|
Nucleic Acids | 1 | 2014 | 188 | 0.400 |
Why?
|
Gene Expression Profiling | 13 | 2021 | 9410 | 0.390 |
Why?
|
Genome, Viral | 2 | 2020 | 665 | 0.360 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2022 | 5296 | 0.330 |
Why?
|
Polyomavirus | 2 | 2020 | 234 | 0.320 |
Why?
|
Lung Neoplasms | 7 | 2022 | 13312 | 0.320 |
Why?
|
Arenavirus | 1 | 2008 | 8 | 0.310 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2018 | 1741 | 0.300 |
Why?
|
PTEN Phosphohydrolase | 3 | 2020 | 1114 | 0.300 |
Why?
|
Genetic Predisposition to Disease | 12 | 2022 | 17854 | 0.290 |
Why?
|
Histiocytosis, Langerhans-Cell | 3 | 2015 | 169 | 0.290 |
Why?
|
DNA-Binding Proteins | 7 | 2019 | 9598 | 0.280 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2022 | 4020 | 0.270 |
Why?
|
Oncogenes | 8 | 2017 | 1223 | 0.270 |
Why?
|
Papillomavirus Infections | 1 | 2018 | 1610 | 0.270 |
Why?
|
Chromosome Aberrations | 1 | 2013 | 1771 | 0.270 |
Why?
|
MAP Kinase Kinase 1 | 3 | 2015 | 331 | 0.270 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2018 | 2911 | 0.260 |
Why?
|
Gene Dosage | 6 | 2018 | 1218 | 0.260 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2024 | 8519 | 0.250 |
Why?
|
DNA Mismatch Repair | 2 | 2019 | 428 | 0.250 |
Why?
|
Tumor Suppressor Proteins | 5 | 2012 | 2803 | 0.250 |
Why?
|
Subtraction Technique | 1 | 2008 | 511 | 0.240 |
Why?
|
Medical Oncology | 2 | 2023 | 2318 | 0.240 |
Why?
|
Genetic Testing | 3 | 2022 | 3535 | 0.240 |
Why?
|
Nuclear Proteins | 9 | 2022 | 5794 | 0.240 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 2 | 2019 | 380 | 0.240 |
Why?
|
Micrococcal Nuclease | 1 | 2003 | 36 | 0.230 |
Why?
|
DNA Helicases | 4 | 2022 | 851 | 0.230 |
Why?
|
Uterine Neoplasms | 3 | 2018 | 1420 | 0.230 |
Why?
|
Ovarian Neoplasms | 6 | 2018 | 4879 | 0.230 |
Why?
|
Colorectal Neoplasms | 4 | 2021 | 6894 | 0.220 |
Why?
|
Genes, Tumor Suppressor | 4 | 2018 | 1062 | 0.220 |
Why?
|
Transcription Factors | 9 | 2022 | 12121 | 0.220 |
Why?
|
Rhabdoid Tumor | 2 | 2018 | 210 | 0.220 |
Why?
|
Humans | 96 | 2024 | 760437 | 0.210 |
Why?
|
GTP-Binding Protein alpha Subunits | 2 | 2014 | 102 | 0.210 |
Why?
|
Polyomavirus Infections | 2 | 2020 | 194 | 0.210 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 2 | 2016 | 194 | 0.210 |
Why?
|
Proto-Oncogene Proteins | 4 | 2014 | 4509 | 0.210 |
Why?
|
Serine | 1 | 2006 | 828 | 0.210 |
Why?
|
Genetic Complementation Test | 1 | 2003 | 555 | 0.210 |
Why?
|
Osteosarcoma | 2 | 2023 | 896 | 0.200 |
Why?
|
Skin Neoplasms | 6 | 2021 | 5815 | 0.200 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2006 | 682 | 0.200 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2023 | 218 | 0.190 |
Why?
|
Nevus | 1 | 2023 | 205 | 0.190 |
Why?
|
Gene Amplification | 4 | 2023 | 1086 | 0.180 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2020 | 328 | 0.180 |
Why?
|
Neoplasm Proteins | 2 | 2018 | 3610 | 0.180 |
Why?
|
Indoles | 4 | 2014 | 1833 | 0.180 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2021 | 1640 | 0.180 |
Why?
|
Polymerase Chain Reaction | 3 | 2017 | 6086 | 0.170 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2019 | 321 | 0.170 |
Why?
|
Bacterial Proteins | 2 | 2003 | 3842 | 0.170 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3777 | 0.170 |
Why?
|
Brain Neoplasms | 6 | 2024 | 9003 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2020 | 15867 | 0.170 |
Why?
|
ras Proteins | 3 | 2014 | 1052 | 0.160 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2019 | 46 | 0.160 |
Why?
|
Sulfonamides | 4 | 2014 | 1973 | 0.160 |
Why?
|
Mullerian Ducts | 2 | 2018 | 203 | 0.160 |
Why?
|
Papillomaviridae | 3 | 2024 | 1119 | 0.160 |
Why?
|
Breast Neoplasms, Male | 1 | 2020 | 219 | 0.160 |
Why?
|
Melanoma | 5 | 2023 | 5704 | 0.160 |
Why?
|
Adnexal Diseases | 1 | 2019 | 105 | 0.160 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2021 | 237 | 0.160 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2019 | 191 | 0.160 |
Why?
|
Cell Transformation, Viral | 1 | 2020 | 526 | 0.150 |
Why?
|
Protein Kinase Inhibitors | 5 | 2021 | 5662 | 0.150 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2018 | 101 | 0.150 |
Why?
|
Pituitary Neoplasms | 2 | 2017 | 1324 | 0.150 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2016 | 0.150 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2014 | 726 | 0.150 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14661 | 0.150 |
Why?
|
Carcinoma in Situ | 2 | 2016 | 791 | 0.150 |
Why?
|
Aged | 32 | 2024 | 168840 | 0.150 |
Why?
|
Virus Integration | 1 | 2020 | 304 | 0.150 |
Why?
|
Adenoma | 2 | 2019 | 2157 | 0.150 |
Why?
|
Aged, 80 and over | 19 | 2021 | 58859 | 0.150 |
Why?
|
Female | 48 | 2024 | 391875 | 0.140 |
Why?
|
Tennessee | 1 | 2017 | 120 | 0.140 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 590 | 0.140 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2021 | 1624 | 0.140 |
Why?
|
BRCA2 Protein | 1 | 2022 | 799 | 0.140 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2003 | 1133 | 0.140 |
Why?
|
Chromosomes, Human | 2 | 2016 | 442 | 0.140 |
Why?
|
Signal Transduction | 9 | 2018 | 23397 | 0.140 |
Why?
|
Genes, ras | 4 | 2016 | 653 | 0.140 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2020 | 339 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2020 | 9267 | 0.140 |
Why?
|
Head and Neck Neoplasms | 3 | 2024 | 2891 | 0.130 |
Why?
|
Bone Neoplasms | 2 | 2023 | 2525 | 0.130 |
Why?
|
Mesonephroma | 1 | 2015 | 21 | 0.130 |
Why?
|
Stomach Neoplasms | 2 | 2019 | 1428 | 0.130 |
Why?
|
Information Dissemination | 1 | 2024 | 1127 | 0.130 |
Why?
|
Frameshift Mutation | 2 | 2018 | 392 | 0.130 |
Why?
|
BRCA1 Protein | 1 | 2022 | 1146 | 0.130 |
Why?
|
Carcinoma, Basal Cell | 1 | 2021 | 559 | 0.130 |
Why?
|
Middle Aged | 34 | 2024 | 220382 | 0.130 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2015 | 56 | 0.120 |
Why?
|
Ovarian Cysts | 1 | 2016 | 108 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2023 | 952 | 0.120 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3734 | 0.120 |
Why?
|
Adult | 33 | 2024 | 220781 | 0.120 |
Why?
|
Port-Wine Stain | 1 | 2014 | 33 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2018 | 5292 | 0.120 |
Why?
|
Prognosis | 10 | 2023 | 29551 | 0.120 |
Why?
|
Adenosarcoma | 1 | 2014 | 36 | 0.120 |
Why?
|
Craniopharyngioma | 1 | 2017 | 277 | 0.120 |
Why?
|
Proto-Oncogene Proteins A-raf | 1 | 2014 | 9 | 0.120 |
Why?
|
Gene Fusion | 1 | 2017 | 354 | 0.120 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2014 | 696 | 0.120 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 532 | 0.120 |
Why?
|
Facial Dermatoses | 1 | 2014 | 86 | 0.120 |
Why?
|
Neuroblastoma | 1 | 2022 | 1250 | 0.120 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 71 | 0.120 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2012 | 641 | 0.110 |
Why?
|
Sequence Analysis | 1 | 2014 | 240 | 0.110 |
Why?
|
Vulvar Neoplasms | 1 | 2016 | 263 | 0.110 |
Why?
|
Survival Analysis | 4 | 2020 | 10075 | 0.110 |
Why?
|
Comparative Genomic Hybridization | 4 | 2017 | 473 | 0.110 |
Why?
|
Rhabdomyoma | 1 | 2013 | 56 | 0.110 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2016 | 328 | 0.110 |
Why?
|
Male | 34 | 2024 | 360035 | 0.110 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2021 | 2509 | 0.110 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 637 | 0.110 |
Why?
|
Antineoplastic Agents | 4 | 2015 | 13616 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2014 | 370 | 0.100 |
Why?
|
Germ-Line Mutation | 3 | 2022 | 1850 | 0.100 |
Why?
|
Encyclopedias as Topic | 1 | 2012 | 19 | 0.100 |
Why?
|
Muscle Neoplasms | 1 | 2013 | 130 | 0.100 |
Why?
|
Chromosome Deletion | 2 | 2014 | 1387 | 0.100 |
Why?
|
Glioma | 3 | 2013 | 3434 | 0.100 |
Why?
|
Phylogeny | 1 | 2020 | 2806 | 0.100 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2012 | 452 | 0.100 |
Why?
|
Breast Neoplasms | 5 | 2023 | 20985 | 0.100 |
Why?
|
Adenocarcinoma, Mucinous | 1 | 2016 | 517 | 0.100 |
Why?
|
Pericytes | 1 | 2014 | 293 | 0.100 |
Why?
|
Colonic Neoplasms | 2 | 2016 | 2529 | 0.100 |
Why?
|
Ovary | 1 | 2016 | 958 | 0.090 |
Why?
|
Sarcoma | 1 | 2022 | 1791 | 0.090 |
Why?
|
Chordoma | 1 | 2014 | 346 | 0.090 |
Why?
|
Reproducibility of Results | 4 | 2021 | 20078 | 0.090 |
Why?
|
Cadherins | 1 | 2016 | 904 | 0.090 |
Why?
|
Genes, myc | 1 | 2012 | 390 | 0.090 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 4567 | 0.090 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 507 | 0.090 |
Why?
|
Pons | 1 | 2011 | 240 | 0.090 |
Why?
|
Diffusion of Innovation | 1 | 2015 | 726 | 0.090 |
Why?
|
raf Kinases | 1 | 2011 | 118 | 0.090 |
Why?
|
Prostatectomy | 1 | 2018 | 1821 | 0.090 |
Why?
|
Biopsy | 4 | 2018 | 6765 | 0.090 |
Why?
|
Genome | 2 | 2009 | 1739 | 0.090 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2014 | 478 | 0.090 |
Why?
|
Angiomyolipoma | 1 | 2011 | 186 | 0.090 |
Why?
|
Inheritance Patterns | 1 | 2012 | 340 | 0.080 |
Why?
|
Brain Stem Neoplasms | 1 | 2011 | 190 | 0.080 |
Why?
|
Peritoneal Neoplasms | 1 | 2016 | 711 | 0.080 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2010 | 93 | 0.080 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 716 | 0.080 |
Why?
|
Uveal Neoplasms | 1 | 2012 | 341 | 0.080 |
Why?
|
Databases, Genetic | 3 | 2016 | 1738 | 0.080 |
Why?
|
Gallbladder Neoplasms | 1 | 2011 | 190 | 0.080 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 659 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1889 | 0.080 |
Why?
|
Wolffian Ducts | 2 | 2019 | 27 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2011 | 3446 | 0.080 |
Why?
|
DNA Primers | 2 | 2011 | 2820 | 0.080 |
Why?
|
Hedgehog Proteins | 1 | 2013 | 768 | 0.080 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2011 | 212 | 0.080 |
Why?
|
Cohort Studies | 8 | 2021 | 41366 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1994 | 0.080 |
Why?
|
Neoplasm Staging | 7 | 2020 | 11096 | 0.080 |
Why?
|
Lymphoproliferative Disorders | 1 | 2012 | 533 | 0.080 |
Why?
|
Codon | 1 | 2009 | 602 | 0.070 |
Why?
|
Cell Line, Tumor | 10 | 2014 | 16945 | 0.070 |
Why?
|
Genetic Variation | 2 | 2017 | 6570 | 0.070 |
Why?
|
Gene Deletion | 2 | 2013 | 2667 | 0.070 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2011 | 487 | 0.070 |
Why?
|
Databases, Nucleic Acid | 1 | 2008 | 204 | 0.070 |
Why?
|
Protein Methyltransferases | 1 | 2006 | 53 | 0.070 |
Why?
|
Molecular Targeted Therapy | 3 | 2024 | 2805 | 0.070 |
Why?
|
Astrocytoma | 1 | 2011 | 775 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2013 | 2453 | 0.070 |
Why?
|
DNA, Neoplasm | 3 | 2020 | 1745 | 0.070 |
Why?
|
Telomere | 1 | 2012 | 931 | 0.070 |
Why?
|
Tumor Burden | 2 | 2022 | 1887 | 0.070 |
Why?
|
HL-60 Cells | 1 | 2006 | 363 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2014 | 3590 | 0.060 |
Why?
|
Mutation, Missense | 2 | 2012 | 2571 | 0.060 |
Why?
|
Genetic Markers | 1 | 2012 | 2612 | 0.060 |
Why?
|
Phenotype | 4 | 2018 | 16585 | 0.060 |
Why?
|
Mass Spectrometry | 4 | 2014 | 2189 | 0.060 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2013 | 1248 | 0.060 |
Why?
|
Young Adult | 9 | 2022 | 59068 | 0.060 |
Why?
|
High-Throughput Screening Assays | 1 | 2011 | 934 | 0.060 |
Why?
|
Early Detection of Cancer | 1 | 2019 | 3183 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2010 | 988 | 0.060 |
Why?
|
Embryonic Development | 1 | 2009 | 717 | 0.060 |
Why?
|
Genetic Techniques | 1 | 2007 | 427 | 0.060 |
Why?
|
Clinical Trials as Topic | 3 | 2024 | 7996 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2022 | 11070 | 0.060 |
Why?
|
Benzimidazoles | 1 | 2009 | 855 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2047 | 0.060 |
Why?
|
Child, Preschool | 8 | 2024 | 42209 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9326 | 0.060 |
Why?
|
DNA Damage | 3 | 2012 | 2441 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2013 | 2819 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4649 | 0.060 |
Why?
|
beta Catenin | 2 | 2023 | 1040 | 0.060 |
Why?
|
Meningioma | 1 | 2013 | 1218 | 0.060 |
Why?
|
Alleles | 3 | 2013 | 6908 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2006 | 855 | 0.060 |
Why?
|
Cell Movement | 1 | 2016 | 5198 | 0.060 |
Why?
|
Phosphorylation | 3 | 2015 | 8311 | 0.060 |
Why?
|
Paraffin Embedding | 2 | 2017 | 302 | 0.050 |
Why?
|
Trans-Activators | 1 | 2013 | 2858 | 0.050 |
Why?
|
Patient Selection | 1 | 2015 | 4240 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 17639 | 0.050 |
Why?
|
Social Class | 1 | 2012 | 2003 | 0.050 |
Why?
|
Zebrafish Proteins | 1 | 2009 | 1012 | 0.050 |
Why?
|
Protein Sorting Signals | 1 | 2003 | 279 | 0.050 |
Why?
|
Formaldehyde | 2 | 2017 | 358 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15257 | 0.050 |
Why?
|
GTP-Binding Protein alpha Subunits, Gq-G11 | 2 | 2014 | 147 | 0.050 |
Why?
|
Smoking | 2 | 2017 | 9046 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6471 | 0.050 |
Why?
|
Child | 10 | 2024 | 80086 | 0.050 |
Why?
|
Prospective Studies | 5 | 2022 | 54339 | 0.050 |
Why?
|
Amino Acid Substitution | 3 | 2012 | 1737 | 0.050 |
Why?
|
Prostatic Neoplasms | 2 | 2018 | 11095 | 0.050 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2023 | 181 | 0.050 |
Why?
|
Infant | 6 | 2024 | 36183 | 0.050 |
Why?
|
Esophageal Neoplasms | 1 | 2012 | 1646 | 0.050 |
Why?
|
Histones | 1 | 2012 | 2577 | 0.050 |
Why?
|
Protein Conformation | 1 | 2009 | 3969 | 0.050 |
Why?
|
Protein Isoforms | 1 | 2006 | 1697 | 0.050 |
Why?
|
GTP Phosphohydrolases | 2 | 2015 | 516 | 0.050 |
Why?
|
Algorithms | 2 | 2014 | 14002 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2485 | 0.050 |
Why?
|
Base Sequence | 3 | 2013 | 12449 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2014 | 2331 | 0.050 |
Why?
|
Adolescent | 8 | 2024 | 88196 | 0.040 |
Why?
|
Prevalence | 1 | 2017 | 15698 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6813 | 0.040 |
Why?
|
Exons | 2 | 2019 | 2392 | 0.040 |
Why?
|
Neoplasm Invasiveness | 3 | 2014 | 3587 | 0.040 |
Why?
|
Fluorescent Antibody Technique | 2 | 2016 | 2468 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2007 | 4630 | 0.040 |
Why?
|
Research Design | 2 | 2012 | 6168 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12698 | 0.040 |
Why?
|
Transfection | 1 | 2006 | 5776 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2014 | 2895 | 0.040 |
Why?
|
Protein Binding | 2 | 2009 | 9340 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2014 | 12653 | 0.040 |
Why?
|
Zebrafish | 1 | 2009 | 3002 | 0.040 |
Why?
|
Protein Transport | 1 | 2003 | 1965 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 611 | 0.040 |
Why?
|
Germ Cells | 1 | 2021 | 634 | 0.040 |
Why?
|
Models, Genetic | 1 | 2007 | 3445 | 0.040 |
Why?
|
Homeodomain Proteins | 1 | 2006 | 2413 | 0.040 |
Why?
|
Introns | 1 | 2019 | 981 | 0.030 |
Why?
|
Chromogranins | 1 | 2017 | 161 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3782 | 0.030 |
Why?
|
Databases, Factual | 1 | 2012 | 7948 | 0.030 |
Why?
|
Pedigree | 2 | 2016 | 4586 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2012 | 3344 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2024 | 26280 | 0.030 |
Why?
|
Gene Rearrangement | 1 | 2021 | 1125 | 0.030 |
Why?
|
Cell Lineage | 2 | 2018 | 2539 | 0.030 |
Why?
|
Models, Biological | 1 | 2012 | 9462 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 267 | 0.030 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 195 | 0.030 |
Why?
|
Microsatellite Instability | 1 | 2019 | 715 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2018 | 11526 | 0.030 |
Why?
|
Receptor, EphA3 | 1 | 2014 | 13 | 0.030 |
Why?
|
Genes, myb | 1 | 2014 | 18 | 0.030 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 1485 | 0.030 |
Why?
|
Hong Kong | 1 | 2015 | 166 | 0.030 |
Why?
|
Kidney Neoplasms | 1 | 2011 | 4241 | 0.030 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 1 | 2018 | 323 | 0.030 |
Why?
|
BALB 3T3 Cells | 1 | 2014 | 10 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2021 | 80430 | 0.030 |
Why?
|
Lipopolysaccharides | 1 | 2022 | 2205 | 0.030 |
Why?
|
Uterus | 1 | 2018 | 649 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1264 | 0.030 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 184 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2016 | 956 | 0.030 |
Why?
|
Genetic Association Studies | 2 | 2014 | 2723 | 0.030 |
Why?
|
Langerhans Cells | 1 | 2014 | 170 | 0.030 |
Why?
|
Software | 1 | 2007 | 4426 | 0.030 |
Why?
|
Receptor, erbB-2 | 1 | 2023 | 2553 | 0.030 |
Why?
|
DNA, Viral | 1 | 2020 | 2201 | 0.030 |
Why?
|
Genes, erbB-1 | 1 | 2013 | 162 | 0.030 |
Why?
|
Valine | 1 | 2014 | 408 | 0.030 |
Why?
|
Topoisomerase Inhibitors | 1 | 2012 | 19 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 384 | 0.030 |
Why?
|
Animals | 7 | 2014 | 168253 | 0.030 |
Why?
|
Disease Progression | 3 | 2016 | 13484 | 0.030 |
Why?
|
Chromosome Duplication | 1 | 2012 | 75 | 0.030 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13445 | 0.020 |
Why?
|
Apoptosis | 3 | 2016 | 9468 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 191 | 0.020 |
Why?
|
Neurofibromin 2 | 1 | 2013 | 270 | 0.020 |
Why?
|
Phosphatidylethanolamine Binding Protein | 1 | 2011 | 8 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1084 | 0.020 |
Why?
|
Cell Cycle | 2 | 2010 | 2929 | 0.020 |
Why?
|
Social Identification | 1 | 2012 | 108 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2011 | 166 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1693 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2006 | 18955 | 0.020 |
Why?
|
Validation Studies as Topic | 1 | 2011 | 162 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2018 | 1534 | 0.020 |
Why?
|
Neoplasm Metastasis | 2 | 2012 | 4903 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2011 | 200 | 0.020 |
Why?
|
Sezary Syndrome | 1 | 2011 | 80 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2021 | 2978 | 0.020 |
Why?
|
Tumor Stem Cell Assay | 1 | 2009 | 115 | 0.020 |
Why?
|
Multigene Family | 1 | 2013 | 1077 | 0.020 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2012 | 220 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2014 | 1128 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2016 | 978 | 0.020 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 378 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 807 | 0.020 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2011 | 296 | 0.020 |
Why?
|
Niacinamide | 1 | 2011 | 413 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2016 | 10425 | 0.020 |
Why?
|
Mycosis Fungoides | 1 | 2011 | 170 | 0.020 |
Why?
|
Genes, jun | 1 | 2008 | 69 | 0.020 |
Why?
|
Emigration and Immigration | 1 | 2012 | 396 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39078 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2016 | 12785 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1175 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2647 | 0.020 |
Why?
|
Plasma Cells | 1 | 2012 | 599 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2852 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2011 | 1704 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2011 | 528 | 0.020 |
Why?
|
Mice | 5 | 2014 | 81402 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2016 | 1667 | 0.020 |
Why?
|
SEER Program | 1 | 2013 | 1449 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2016 | 6128 | 0.020 |
Why?
|
Culture | 1 | 2012 | 623 | 0.020 |
Why?
|
Genomic Instability | 1 | 2012 | 709 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2014 | 3592 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 675 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2015 | 7849 | 0.020 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2012 | 633 | 0.020 |
Why?
|
Prejudice | 1 | 2012 | 571 | 0.020 |
Why?
|
Molecular Chaperones | 1 | 2012 | 755 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 614 | 0.020 |
Why?
|
DNA Breaks, Double-Stranded | 1 | 2012 | 612 | 0.020 |
Why?
|
Antigens, CD1 | 1 | 2010 | 439 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2711 | 0.020 |
Why?
|
Cell Size | 1 | 2009 | 624 | 0.020 |
Why?
|
Telomerase | 1 | 2012 | 745 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2016 | 1739 | 0.020 |
Why?
|
Mice, Nude | 1 | 2013 | 3603 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2018 | 2821 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3637 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2011 | 1832 | 0.020 |
Why?
|
HeLa Cells | 1 | 2012 | 3097 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3792 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2014 | 0.020 |
Why?
|
Embryo, Nonmammalian | 1 | 2009 | 903 | 0.020 |
Why?
|
Neuropeptides | 1 | 2011 | 944 | 0.020 |
Why?
|
Mutagenesis | 1 | 2009 | 1233 | 0.020 |
Why?
|
Cholangiocarcinoma | 1 | 2011 | 552 | 0.020 |
Why?
|
Bile Duct Neoplasms | 1 | 2011 | 605 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1956 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4277 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2821 | 0.010 |
Why?
|
Myeloid Cells | 1 | 2009 | 823 | 0.010 |
Why?
|
Estrogen Receptor alpha | 1 | 2008 | 581 | 0.010 |
Why?
|
Health Services Research | 1 | 2012 | 1811 | 0.010 |
Why?
|
Logistic Models | 1 | 2019 | 13240 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12969 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2010 | 1753 | 0.010 |
Why?
|
DNA Repair | 1 | 2012 | 2044 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12054 | 0.010 |
Why?
|
Risk Factors | 3 | 2016 | 74055 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12429 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8826 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9533 | 0.010 |
Why?
|
Genetic Loci | 1 | 2010 | 2626 | 0.010 |
Why?
|
Gene Expression | 1 | 2013 | 7582 | 0.010 |
Why?
|
Pyrimidines | 1 | 2012 | 3024 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5790 | 0.010 |
Why?
|
Hematopoiesis | 1 | 2009 | 2049 | 0.010 |
Why?
|
Pyridines | 1 | 2011 | 2868 | 0.010 |
Why?
|
Proteome | 1 | 2008 | 1861 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2012 | 7817 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10538 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3541 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2011 | 4319 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18216 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 64591 | 0.010 |
Why?
|